Hólyagrák: vizsgálatok itt: Oroszország
1 of 2 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleSequential Gemcitabine Plus Docetaxel Versus Gemcitabine Plus Mitomycin C for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer
- Where
- Moscow
- Életkor
- 18 év and over
- People
- 228
- Run by
- Blokhin's Russian Cancer Research Center
See details and how to joinNCT07747740